Abu Dhabi-based investment and holding company, ADQ has entered into an agreement with UAE’s agribusiness investment company, E20 Investment in order to establish a new animal health platform in the emirates, representing a landmark milestone for the region’s animal healthcare industry.
According to the statement, the animal health platform will initially comprise a cutting-edge animal vaccine manufacturing facility and a complex with two state-of-the-art animal hospitals.
Once operational, the facilities will further enhance Abu Dhabi’s position as a regional leader in high-end veterinary services for horses and camels while producing the most technologically advanced animal vaccines serving the Middle East and Africa (MEA) region.
Mr. Fahad Al Qassim, Executive Director, Healthcare & Life Sciences Portfolio at ADQ said that, “Leveraging our healthcare and life sciences expertise, we have identified an opportunity to create an adjacent platform in animal health.”
“By creating a joint venture with E20, we will capitalize on Abu Dhabi’s strong market potential for animal vaccine production and maintaining the health and welfare of prized animals, such as horses and camels,” Mr. Al Qassin further added.
Mr. Sultan Al Jaberi, CEO of E20 Investment Limited stated that, “Together with ADQ, we will bring world-class vaccine technology to the UAE and join hands with our partner to foster local production and serve lucrative markets in the MENA region and beyond.”
Earlier this year, UAE’s leading investment firm Alpha Dhabi Holding (ADH) signed an agreement with ADQ to create the largest healthcare provider in the Emirates through its subsidiary Pure Health Medical Supplies.
